stockrowIndivior Pharmaceuticals Inc.
SUPN Healthcare Drug Manufacturers Specialty & Generic
Indivior Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 4.29% from fiscal 2024.
- Revenue
- +13.4%
- EPS
- +241.5%
- Free cash flow
- +240.7%
- Total debt
- +51.6%
Quarter to September 2026, against a year earlier
Follow SUPN
Alert me
Indivior Pharmaceuticals Inc. (SUPN) Operating margin
Indivior Pharmaceuticals Inc.'s operating margin over the twelve months to 30 September 2026 was 40.6%, up 19.4 percentage points from fiscal 2025 (21.2%). Over the past ten years it has ranged from −24.1% (fiscal 2020) to 34.1% (fiscal 2015); the current reading is higher than 64% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 21.2% | 17.95 |
| FY2024 | 3.20% | 17.66 |
| FY2023 | −14.5% | (5.03) |
| FY2022 | −9.43% | (36.36) |
| FY2021 | 26.9% | 51.04 |
| FY2020 | −24.1% | (46.79) |
| FY2019 | 22.7% | (6.37) |
| FY2018 | 29.1% | 11.39 |
| FY2017 | 17.7% | 3.58 |
| FY2016 | 14.1% | (20.04) |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 50.8% | 4.48 |
| Jun 2026 | 46.4% | 3.14 |
| Mar 2026 | 43.2% | 20.81 |
| Dec 2025 | 22.4% | 8.40 |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| SUPN Indivior Pharmaceuticals Inc. | 40.6% |
| LQDA Liquidia Corporation compare | 37.4% |
| LNTH Lantheus Holdings, Inc. compare | 18.6% |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 15.0% |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 13.8% |
| RDY Dr. Reddy's Laboratories Ltd compare | 9.20% |
| ALKS Alkermes plc compare | 3.66% |
| AMLX Amylyx Pharmaceuticals, Inc. compare | 0.00% |
| HIMS Hims & Hers Health, Inc. compare | −5.99% |
| Drug Manufacturers Specialty & Generic industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on SUPN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement